BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11002517)

  • 1. [Surgical treatment of stage I germ cell tumor of the testis].
    Rubio Briones J; Solsona Narbón E
    Arch Esp Urol; 2000; 53(6):491-9. PubMed ID: 11002517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laparoscopic lymphadenectomy in the treatment of stage I non-seminomatous germ cell tumors].
    Hernández Fernández C; Castaño González I; Escribano Patiño G; de Palacio España A
    Arch Esp Urol; 2000; 53(6):500-4. PubMed ID: 11002518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of stage I germ cell tumors of the testis].
    Santomé Couto L; Tabernero Caturla JM; Villavicencio Mavrich H; Valentí Moreno V
    Arch Esp Urol; 2000; 53(6):474-86. PubMed ID: 11002515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
    Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
    Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of stage I nonseminomatous germ-cell tumors.
    Thomas J; Aleman M; Dreicer R; Klein EA
    Semin Urol Oncol; 2002 Nov; 20(4):220-6. PubMed ID: 12489053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
    Foster RS; Donohue JP
    J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
    Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
    J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
    Stephenson AJ; Sheinfeld J
    Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic approach to retroperitoneal lymph node dissection.
    Gerber GS; Rukstalis DB
    Semin Surg Oncol; 1996; 12(2):121-5. PubMed ID: 8685577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of stage I nonseminomatous germ cell tumours after orchiectomy].
    Culine S; ;
    Prog Urol; 2004 Dec; 14(6):1112-8. PubMed ID: 15751403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients after retroperitoneal lymphadenectomy for clinical stage I nonseminomatous germ cell tumour of the testis.
    Hornák M; Zvara V; Ondrus D; Bárdos A
    Czech Med; 1987; 10(2):109-16. PubMed ID: 2820669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
    Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
    J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
    Eggener SE; Carver BS; Sharp DS; Motzer RJ; Bosl GJ; Sheinfeld J
    J Urol; 2007 Mar; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testicular germ cell tumors: prognosis].
    Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
    Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lymphadenectomy for testicular cancer: indications, controversies, and complications.
    Tarin T; Carver B; Sheinfeld J
    Urol Clin North Am; 2011 Nov; 38(4):439-49, vi. PubMed ID: 22045175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.